
BUPROCARE 0.4MG TABLET
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Buprenorphine (0.4mg)
Overview BUPROCARE 0.4MG TABLET
BUPROCARE 0.4MG tablets are indicated for managing opioid (morphine) addiction. They alleviate withdrawal symptoms associated with opioid cessation. This medication forms part of a comprehensive treatment plan incorporating counseling and lifestyle adjustments. BUPROCARE 0.4MG tablets are exclusively prescribed to patients aged 16 and older. Potential for dependence necessitates strict adherence to the physician's instructions. Treatment may encompass psychosocial support services. Administration is independent of food intake. Consistent daily use, as directed by your doctor, is crucial; missed doses diminish efficacy. Frequently reported side effects include fatigue, opioid withdrawal symptoms, unease, jitters, lightheadedness, cephalalgia, somnolence, bowel looseness, queasiness, emesis, and stomach discomfort. Persistent or worsening side effects warrant immediate medical consultation. Your physician can offer strategies for mitigation or symptom reduction. Prior to commencing treatment, inform your doctor of any pre-existing health conditions or medications currently in use to ensure suitability. Pregnant or lactating individuals must seek medical advice before using this medication.
Uses of BUPROCARE 0.4MG TABLET
Morphine addiction; management of significant to intense pain
Major Benefits of BUPROCARE 0.4MG TABLET:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the BUPROCARE 0.4MG TABLET whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be independent of them, however, maintaining a consistent daily intake time is recommended.
Common Side effects of BUPROCARE 0.4MG TABLET:
- Headache
- Drug withdrawal syndrome
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sleepiness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use BUPROCARE 0.4MG TABLET:
Administer BUPROCARE 0.4MG TABLETS precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. This medication can be consumed with or without food, though consistent timing is recommended.
How BUPROCARE 0.4MG TABLET works:
Suboxone 0.4mg tablets function as a partial opioid agonist, mitigating withdrawal symptoms in individuals discontinuing opioid use by mimicking the effects of such medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining BUPROCARE 0.4MG TABLETS with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using BUPROCARE 0.4MG TABLETS during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of BUPROCARE 0.4MG TABLETS while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking BUPROCARE 0.4MG TABLETS may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use 0.4mg BUPROCARE tablets cautiously. A dose modification of BUPROCARE 0.4mg tablets may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use 0.4mg BUPROCARE tablets cautiously, potentially requiring dose modification. Physician consultation is advised. BUPROCARE 0.4mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take BUPROCARE 0.4MG TABLET :
NA
Facts to Know About BUPROCARE 0.4MG TABLET
| Label | Value |
|---|---|
| Chemical Category | Phenanthrene Derivatives |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | Partial Opioid Agonists |
